A gentle ache, a missed period, a feeling of being off; women often carry on through symptoms that could signal deeper ...

Mirvetuximab soravtansine (MIRV; Elahere; AbbVie) demonstrated significant efficacy and an acceptable safety profile in the treatment of recurrent ovarian cancer, showing particular promise in ...

The global ovarian cancer diagnostics market is projected to grow at a compound annual growth rate (CAGR) of approximately 6% ...

A Pune woman's baffling abdominal pain led doctors on a diagnostic journey, initially pointing to benign ovarian masses.

Inherited changes in the tumor suppressor genes BRCA1 and BRCA2, raise lifetime risk substantially. For ovarian cancer, the ...

Siobhan Ryan, 63, is one of 3,000 people in the UK who claim that either they or their family members have developed forms of ...

"The goal is to try to delay menopause, so you can recover more years of overall health and protection from chronic diseases.

My year of unraveling” is how a despairing Christy Morrill described nightmarish months when his immune system hijacked his ...

OBI-902 is the first ADC utilizing OBI’s proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / ...

As GLP-1s go mainstream, it's more likely than not someone at your Thanksgiving table will look or eat differently, ...

CAR T-cell therapies have revolutionized blood cancer treatment. Now, researchers with our Human Health Therapeutics Research ...

Key points A 20-year-old pediatric cancer survivor presented to her local oncology centre in southwestern Ontario with right supraclavicular adenopathy. She had a history of stage IIA Hodgkin lymphoma ...